Pulmo BioTech Inc. Announces Attendance at RSNA 2010 NEW YORK, July 6, 2010 (GLOBE NEWSWIRE) -- Pulmo BioTech Inc. (OTCBB:PLMO) (Frankfurt:PB0) announces that later this year it intends to exhibit at RSNA 2010, the 96th Scientific Assembly & Annual...

Pulmo BioTech Inc. Has Revealed That Its PulmoBind(TM) Pulmonary Vascular Diagnostic Product Candidate May Have Particular Applicability to Post Operative Patient Care and Diagnostics NEW YORK, June 29, 2010 (GLOBE NEWSWIRE) -- "Pulmonary Embolism (PE) is a potentially fatal condition that occurs when a blood clot forms within the vascular system of the body, becoming detached and...

Pulmo BioTech Inc. Reveals Its PulmoBind(TM) Pulmonary Vascular Diagnostic Product Candidate May Apply to Early Stage Diagnosis of Conditions Afflicting Pulmonary Circulation in Pediatric Population NEW YORK, June 7, 2010 (GLOBE NEWSWIRE) -- "Pulmo BioTech Inc. (OTCBB:PLMO) (Frankfurt:PB0) has announced that early indications are that its PulmoBind™ product candidate has the potential for...

Pulmo BioTech Inc. and Dr. Jocelyn Dupuis Outline Original Concept Details of Molecular Imaging Technology at 3rd International Neonatal and Childhood Pulmonary Disease Conference NEW YORK, May 24, 2010 (GLOBE NEWSWIRE) -- Dr. Jocelyn Dupuis, the Chief Scientific Officer of Pulmo BioTech Inc. (OTCBB:PLMO) (Frankfurt:PB0) and the originator of the PulmoBind concept, has...